In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy
about
Proximity assays for sensitive quantification of proteinsDifferent Facets of Copy Number Changes: Permanent, Transient, and AdaptiveThe epidermal growth factor receptor variant III (EGFRvIII): where wild things are alteredAdoptive cell therapies for glioblastomaGlial progenitors as targets for transformation in glioma.The challenges and the promise of molecular targeted therapy in malignant gliomas.Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assaysEarly signaling dynamics of the epidermal growth factor receptor.Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapyIn situ Protein Detection for Companion Diagnostics.New horizons in therapeutic antibody discovery: opportunities and challenges versus small-molecule therapeutics.Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaAsymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation.Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.Cyclic trans-phosphorylation in a homodimer as the predominant mechanism of EGFRvIII action and regulation.In situ Analysis of Smoothelin-like 1 and Calmodulin Interactions in Smooth Muscle Cells by Proximity Ligation
P2860
Q26748501-6DE277D2-F0AE-46D8-B96F-794C9265511EQ26769649-01CE3A4B-CBC3-406C-92B6-6DAA48A11539Q27015045-4B332E84-F121-4E77-9FF6-DD285CDEB7B3Q27030863-D7B07DF2-E9C0-43BA-8508-8B0697D2E933Q34735661-FBF58E77-74CE-4E44-B890-D4A9211998B1Q35214534-DC8BD3A9-CDC0-4859-B6D8-EDB245AD7574Q35631966-19FD86B0-3690-49AD-B1A7-639EFB8D9A1AQ36710547-C11C5612-0E19-46B5-A04B-08F2BC466634Q37154421-87B755ED-D8BF-404D-A7AD-52A062152246Q37270405-58706A59-074A-44EC-A232-CF68E41C0E04Q38289992-DD3FD7AF-E484-4823-9B0C-68533232F341Q38722183-C57811C8-AB95-43FD-AC7E-0B021A4F99AFQ38807586-433A9F0B-CBC0-43C8-90D3-A4DE3B7A7538Q42186051-113B6687-468B-44B9-A4CE-9A30E8844331Q42602597-2C8EF220-7BEC-41BE-8FBA-39258D630209Q48203761-823FAED4-4D59-417D-9BD8-38923E339BF7Q50324498-CF9F31FD-DE2A-414F-97FA-A6B7FB4BBF82Q56929322-CCF47D0C-EF7A-49A6-A7B9-88BE8EFD5622
P2860
In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@ast
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@en
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@en-gb
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@nl
type
label
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@ast
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@en
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@en-gb
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@nl
prefLabel
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@ast
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@en
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@en-gb
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@nl
P2093
P1476
In situ analysis of mutant EGF ...... to anti-EGFR targeted therapy
@en
P2093
Aaron S Gajadhar
Abhijit Guha
Diana Marcela Muñoz
Elena Bogdanovic
P304
P356
10.1158/1541-7786.MCR-11-0531
P407
P577
2012-03-01T00:00:00Z